To validate the immune modulatory effects of NSCs expressing IDO, we carried out a mixed leukocyte reaction (MLR) in vitro and transplanted NSCs expressing IDO into an experimental autoimmune encephalomyelitis (EAE) animal model, which mimics human multiple sclerosis (MS) [24]. The gene discussed is IDO1; the disease is multiple sclerosis.